The Effect and Optimal Parameters of Repetitive Transcranial Magnetic Stimulation on Poststroke Dysphagia: A Meta-Analysis of Randomized Controlled Trials

• Published in: Frontiers in neuroscience 2022-04, Vol.16, p.845737-845737
• Main Authors: Qiao, Jia, Ye, Qiu-Ping, Wu, Zhi-Min, Dai, Yong, Dou, Zu-Lin
• Format: Article
• Language: English
• Subjects: meta-analysis; Neuroscience; parameters; poststroke dysphagia (PSD); randomized controlled trial; repetitive transcranial magnetic stimulation (rTMS)
• ISSN: 1662-4548; 1662-453X; 1662-453X
• DOI: 10.3389/fnins.2022.845737

The objectives of the study were to evaluate the efficacy of repetitive transcranial magnetic stimulation (rTMS) treatment for poststroke dysphagia (PSD) and explore the optimal stimulation parameters. The databases of Medline, Embase, Web of Science, and Cochrane Library were searched from the establishment to June 2021. All randomized controlled trials about rTMS treatment for PSD were enrolled. Dysphagia Grade (DG) and Penetration Aspiration Scale (PAS) were applied as the major dysphagia severity rating scales to evaluate the outcomes. A total of 12 clinical randomized controlled studies were included in our study. The summary effect size indicated that rTMS had a positive effect on PSD (SMD = -0.67, < 0.001). The subgroup analysis for treatment duration and different stroke stages showed significant differences (treatment duration >5 days: SMD = -0.80, < 0.001; subacute phase after stroke: SMD = -0.60, < 0.001). Furthermore, no significant differences were observed among the other stimulation parameter subgroups (including stimulation frequency, location, and a single stimulation time) ( > 0.05). rTMS is beneficial to the recovery of PSD patients, while an intervention of more than 5 days and in the subacute phase after stroke might bring new strategies and rational therapeutics to the treatment of PSD. http://www.crd.york.ac.uk/PROSPERO/, identifier: CRD42022299469.